Your browser doesn't support javascript.
loading
European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel.
Sylvester, Richard J; Rodríguez, Oscar; Hernández, Virginia; Turturica, Diana; Bauerová, Lenka; Bruins, Harman Max; Bründl, Johannes; van der Kwast, Theo H; Brisuda, Antonin; Rubio-Briones, José; Seles, Maximilian; Hentschel, Anouk E; Kusuma, Venkata R M; Huebner, Nicolai; Cotte, Juliette; Mertens, Laura S; Volanis, Dimitrios; Cussenot, Olivier; Subiela Henríquez, Jose D; de la Peña, Enrique; Pisano, Francesca; Pesl, Michael; van der Heijden, Antoine G; Herdegen, Sonja; Zlotta, Alexandre R; Hacek, Jaromir; Calatrava, Ana; Mannweiler, Sebastian; Bosschieter, Judith; Ashabere, David; Haitel, Andrea; Côté, Jean-François; El Sheikh, Soha; Lunelli, Luca; Algaba, Ferran; Alemany, Isabel; Soria, Francesco; Runneboom, Willemien; Breyer, Johannes; Nieuwenhuijzen, Jakko A; Llorente, Carlos; Molinaro, Luca; Hulsbergen-van de Kaa, Christina A; Evert, Matthias; Kiemeney, Lambertus A L M; N'Dow, James; Plass, Karin; Capoun, Otakar; Soukup, Viktor; Dominguez-Escrig, Jose L.
Affiliation
  • Sylvester RJ; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands. Electronic address: richard.sylvester@skynet.be.
  • Rodríguez O; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Hernández V; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
  • Turturica D; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.
  • Bauerová L; Department of Pathology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.
  • Bruins HM; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Bründl J; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.
  • van der Kwast TH; Laboratory Medicine Program, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.
  • Brisuda A; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic.
  • Rubio-Briones J; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.
  • Seles M; Department of Urology, Medical University of Graz, Graz, Austria.
  • Hentschel AE; Department of Urology, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam, The Netherlands; Department of Surgical Oncology (Urology), Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Kusuma VRM; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.
  • Huebner N; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.
  • Cotte J; Department of Urology, Pitié Salpétrière Hospital, AP-HP, Sorbonne University, Paris, France.
  • Mertens LS; Department of Surgical Oncology (Urology), Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Volanis D; Department of Urology, Royal Free London NHS Foundation Trust, Royal Free Hospital, London, UK.
  • Cussenot O; Department of Urology, Royal Free London NHS Foundation Trust, Royal Free Hospital, London, UK.
  • Subiela Henríquez JD; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • de la Peña E; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
  • Pisano F; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.
  • Pesl M; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.
  • van der Heijden AG; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Herdegen S; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.
  • Zlotta AR; Department of Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.
  • Hacek J; Department of Pathology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic.
  • Calatrava A; Department of Pathology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.
  • Mannweiler S; Department of Pathology, Medical University of Graz, Graz, Austria.
  • Bosschieter J; Department of Urology, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam, The Netherlands.
  • Ashabere D; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.
  • Haitel A; Department of Pathology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.
  • Côté JF; Department of Pathology, Pitié Salpétrière Hospital, AP-HP, Pierre et Marie Curie Medical School, Sorbonne University, Paris, France.
  • El Sheikh S; Department of Pathology, Royal Free London NHS Foundation Trust, Royal Free Hospital, London, UK.
  • Lunelli L; Department of Urology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.
  • Algaba F; Department of Pathology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Alemany I; Department of Pathology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
  • Soria F; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.
  • Runneboom W; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Breyer J; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.
  • Nieuwenhuijzen JA; Department of Urology, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam, The Netherlands.
  • Llorente C; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
  • Molinaro L; Department of Pathology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.
  • Hulsbergen-van de Kaa CA; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Evert M; Department of Pathology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.
  • Kiemeney LALM; Department of Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands.
  • N'Dow J; European Association of Urology Guidelines Office, Arnhem, The Netherlands.
  • Plass K; European Association of Urology Guidelines Office, Arnhem, The Netherlands.
  • Capoun O; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.
  • Soukup V; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.
  • Dominguez-Escrig JL; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.
Eur Urol ; 79(4): 480-488, 2021 04.
Article in En | MEDLINE | ID: mdl-33419683
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urology / Urinary Bladder Neoplasms Type of study: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Eur Urol Year: 2021 Document type: Article Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urology / Urinary Bladder Neoplasms Type of study: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Eur Urol Year: 2021 Document type: Article Country of publication: Switzerland